Oramed Pharmaceuticals Stock Income Statements

Oramed Pharmaceuticals Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Gross Profit

Operating Profit

Net Income

Oramed Pharmaceuticals Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-11-30	2021-08-31	2021-05-31	2021-02-28	2020-11-30	2020-08-31	2020-05-31	2020-02-29	2019-11-30	2019-08-31	2019-05-31	2019-02-28	2018-11-30	2018-08-31	2018-05-31	2018-02-28	2017-11-30	2017-08-31	2017-05-31	2017-02-28	2016-11-30	2016-08-31	2016-05-31	2016-02-29	2015-11-30	2014-05-31	2012-02-29
revenue	674,000	666,000	681,000	682,000	674,000	666,000	674,000	683,000	681,000	665,000	674,000	681,000	681,000	674,000	674,000	681,000	682,000	666,000	674,000	617,000	617,000	604,000	611,000	618,000	617,000	611,000	610,000	353,000	163,000	125,000	812,000	379,011	43,111
cost of revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	55,000	35,000	0	86,000	0	0	0	0	0	187,000	0	0	0	0	0	0
gross profit	674,000	666,000	681,000	682,000	674,000	666,000	674,000	683,000	681,000	665,000	674,000	681,000	681,000	674,000	674,000	681,000	682,000	611,000	639,000	617,000	531,000	604,000	611,000	618,000	617,000	611,000	423,000	353,000	163,000	125,000	812,000	379,011	43,111
operating expenses
research and development	1,821,000	4,427,000	7,277,000	5,347,000	9,179,000	5,836,000	6,410,000	5,844,000	5,502,000	3,869,000	5,774,000	2,968,000	1,925,000	3,320,000	2,022,000	2,200,000	3,861,000	3,114,000	4,347,000	2,734,000	4,194,000	2,724,000	2,327,000	2,536,000	2,267,000	3,125,000	2,353,000	2,783,000	1,718,000	1,307,000	1,901,000	1,089,298	710,647
sales, general and administrative
total operating expenses	4,465,000	5,874,000	10,421,000	8,871,000	12,091,000	11,918,000	8,734,000	8,093,000	6,799,000	5,533,000	6,501,000	3,698,000	2,955,000	4,711,000	3,103,000	3,026,000	4,760,000	4,179,000	5,279,000	3,767,000	5,237,000	3,715,000	3,343,000	3,471,000	2,772,000	3,976,000	2,821,000	3,402,000	2,273,000	2,037,000	2,449,000	1,903,221	940,351
operating income	-3,791,000	-5,208,000	-9,740,000	-8,189,000	-11,417,000	-11,252,000	-8,060,000	-7,410,000	-6,118,000	-4,868,000	-5,827,000	-3,017,000	-2,274,000	-4,037,000	-2,429,000	-2,345,000	-4,078,000	-3,568,000	-4,640,000	-3,150,000	-4,534,000	-3,111,000	-2,732,000	-2,853,000	-2,155,000	-3,365,000	-2,398,000	-3,539,000	-2,110,000	-1,912,000	-2,449,000	-1,903,221	-940,351
net income	-1,194,000	-1,798,000	-8,543,000	-7,253,000	-10,533,000	-10,425,000	-7,890,000	-6,853,000	-5,207,000	-4,608,000	-5,570,000	-2,996,000	-2,284,000	-3,688,000	-2,543,000	-2,280,000	-4,072,000	-3,701,000	-4,302,000	-2,926,000	-4,354,000	-2,916,000	-2,531,000	-2,696,000	-1,965,000	-3,183,000	-2,636,000	-4,760,000	-1,996,000	-1,818,000	-2,390,000	-1,827,902	-985,375

We provide you with 20 years income statements for Oramed Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Oramed Pharmaceuticals stock. Explore the full financial landscape of Oramed Pharmaceuticals stock with our expertly curated income statements.

The information provided in this report about Oramed Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.